Insider Selling: Amicus Therapeutics, Inc. (NASDAQ:FOLD) CEO Sells 7,500 Shares of Stock

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) CEO Bradley L. Campbell sold 7,500 shares of Amicus Therapeutics stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $11.71, for a total value of $87,825.00. Following the sale, the chief executive officer now owns 886,654 shares of the […]

Leave a Reply

Your email address will not be published.

Previous post SATS Reaches Self Reported Market Cap of $633.99 Million (1000SATS)
Next post ON24, Inc. (NYSE:ONTF) CRO Sells $27,787.60 in Stock